Erkoc, P.; von Reumont, B.M.; Lüddecke, T.; Henke, M.; Ulshöfer, T.; Vilcinskas, A.; Fürst, R.; Schiffmann, S.
The Pharmacological Potential of Novel Melittin Variants from the Honeybee and Solitary Bees against Inflammation and Cancer. Toxins 2022, 14, 818.
https://doi.org/10.3390/toxins14120818
AMA Style
Erkoc P, von Reumont BM, Lüddecke T, Henke M, Ulshöfer T, Vilcinskas A, Fürst R, Schiffmann S.
The Pharmacological Potential of Novel Melittin Variants from the Honeybee and Solitary Bees against Inflammation and Cancer. Toxins. 2022; 14(12):818.
https://doi.org/10.3390/toxins14120818
Chicago/Turabian Style
Erkoc, Pelin, Björn Marcus von Reumont, Tim Lüddecke, Marina Henke, Thomas Ulshöfer, Andreas Vilcinskas, Robert Fürst, and Susanne Schiffmann.
2022. "The Pharmacological Potential of Novel Melittin Variants from the Honeybee and Solitary Bees against Inflammation and Cancer" Toxins 14, no. 12: 818.
https://doi.org/10.3390/toxins14120818
APA Style
Erkoc, P., von Reumont, B. M., Lüddecke, T., Henke, M., Ulshöfer, T., Vilcinskas, A., Fürst, R., & Schiffmann, S.
(2022). The Pharmacological Potential of Novel Melittin Variants from the Honeybee and Solitary Bees against Inflammation and Cancer. Toxins, 14(12), 818.
https://doi.org/10.3390/toxins14120818
